Separating Predictive Genetic Testing from Snake Oil: Regulation, Liabilities, and Lost Opportunities
Michael J. Malinowski
Louisiana State University, Baton Rouge - Paul M. Hebert Law Center
Jurimetrics, Vol. 41, No. 1, Fall 2000
This article explores the extent to which completion of maps of the human genome, coupled with the introduction of technology that will accelerate the identification of gene and protein function, have introduced immeasurable potential to advance life science and health care through genetic profiling. In light of definitional uncertainly, the regulatory and legal environment surrounding predictive genetic testing threatens to impede clinical utilization of genetic profiling technologies that could significantly improve human health. Especially given that genetic testing technologies have been stigmatized in the public and medical community, they must enter the marketplace with a regulatory framework that assures safety, efficacy, and market responsibility.
Accepted Paper Series
Date posted: June 19, 2001
© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo3 in 0.671 seconds